Medical research: Putting the brakes on sperm production
Nature Communications
November 14, 2012
Peptide fragments of the protein laminin-gamma3 temporarily halt production of sperm cells when injected into rat testes reports a study published in Nature Communications this week. The work may prove to be the first step in the development of a potential male contraceptive.
Transient changes in the leakiness of a tissue known as the blood-testis barrier are important for proper production of sperm cells and regulated by the protein laminin-gamma3. Yan Cheng and his team identified the regions within the laminin-gamma3 protein that were responsible for this effect. They then went on to show that injections of synthetic peptides corresponding to these laminin-gamma3 fragments into testes disrupted the blood-testis barrier in rats, which impaired sperm production. The effect eased off after the injection, with sperm production returning to normal levels about four months after treatment.
It currently remains unclear, however, whether the injections also reduced the fertility of rats and whether these peptides would have the same effect in humans.
doi: 10.1038/ncomms2171
Research highlights
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature